Next Article in Journal
Highly Efficient and Visible Light Responsive Heterojunction Composites as Dual Photoelectrodes for Photocatalytic Fuel Cell
Previous Article in Journal
Catalytic Isomerization of Dihydroxyacetone to Lactic Acid and Alkyl Lactates over Hierarchical Zeolites Containing Tin
Open AccessArticle

Chloroperoxidase-Mediated Halogenation of Selected Pharmaceutical Micropollutants

Centro de Química and Facultad de Ingeniería Química, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
Tecnológico de Monterrey, School of Engineering and Sciences, Campus Monterrey, Ave. Eugenio Garza Sada 2501, Monterrey 64849, Mexico
Microsystems Technologies Laboratories, MIT, Cambridge, MA 02139, USA
Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA 02139, USA
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Instituto Politécnico Nacional-Centro de Nanociencias y Micro y Nano Tecnología, Ciudad de Mexico 07738, Mexico
Author to whom correspondence should be addressed.
Catalysts 2018, 8(1), 32;
Received: 15 December 2017 / Revised: 9 January 2018 / Accepted: 11 January 2018 / Published: 18 January 2018
The oxidation of eight pharmaceutical micropollutants by chloroperoxidase derived from Caldaromyces fumago using hydrogen peroxide as an electron acceptor is reported. All the tested compounds, namely trazadone, sulfamethoxazole, naproxen, tetracycline, estradiol, ketoconazole, ketorolac, and diclofenac, were found to be substrates for oxidation by chloroperoxidase. The respective oxidation products were identified by electrospray ionization–mass spectrometry. All the products contain at least one chloride atom in their structure after the enzymatic oxidation. Degradability experiments indicated that most of the reaction products are more biodegradable than the corresponding unmodified compounds. The enzyme was found to be catalytically active in effluent from a water treatment facility, transforming the micropollutants with high reaction rates and conversions. The enzyme was immobilized in chitosan macrospheres, which allowed the catalyst to be recycled for up to three treatment cycles in simulated samples of treated residual water. The conversion was high in the first two cycles; however, in the third, a 50% reduction in the capacity of the enzyme to oxidize ketorolac was observed. Additionally, immobilization improved the performance of the enzyme over a wider pH range, achieving the conversion of ketorolac at pH 5, while the free enzyme was not active at this pH. Overall, the results of this study suggest that chloroperoxidase represents a powerful potential catalyst in terms of its catalytic activity for the transformation of pharmaceutical micropollutants. View Full-Text
Keywords: chloroperoxidase; environmental biocatalysis; pharmaceutical micropollutants chloroperoxidase; environmental biocatalysis; pharmaceutical micropollutants
Show Figures

Graphical abstract

MDPI and ACS Style

García-Zamora, J.L.; León-Aguirre, K.; Quiroz-Morales, R.; Parra-Saldívar, R.; Gómez-Patiño, M.B.; Arrieta-Baez, D.; Rebollar-Pérez, G.; Torres, E. Chloroperoxidase-Mediated Halogenation of Selected Pharmaceutical Micropollutants. Catalysts 2018, 8, 32.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

Back to TopTop